Ptc Therapeutics (PTCT) Other Non-Current Assets (2012 - 2026)

Ptc Therapeutics' Other Non-Current Assets history runs 15 years deep, the most recent figure standing at $22.6 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 5.74% year-over-year to $22.6 million in Q1 2026; TTM through Mar 2026 was $22.6 million, a 5.74% increase from a year earlier, with the FY2025 full-year figure at $18.3 million, down 11.6% from the prior year.
• Other Non-Current Assets improved to $22.6 million in Q1 2026 per PTCT's latest filing, from $18.3 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $60.3 million in Q2 2022 and bottomed at $18.3 million in Q4 2025.
• The 5-year median for Other Non-Current Assets is $25.3 million (2024), against an average of $33.0 million.
• Across the five-year window, Other Non-Current Assets gained 7.85% in 2023 and tumbled 48.73% in 2024, its largest moves.
• Year by year, Other Non-Current Assets stood at $48.6 million in 2022, then slipped by 25.39% to $36.2 million in 2023, then slumped by 42.88% to $20.7 million in 2024, then retreated by 11.6% to $18.3 million in 2025, then rose by 23.74% to $22.6 million in 2026.
• Per Business Quant, the three latest PTCT Other Non-Current Assets figures stand at $22.6 million (Q1 2026), $18.3 million (Q4 2025), and $19.4 million (Q3 2025).